by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) is now diagnosed biologically. Since subjective cognitive decline (SCD) may indicate preclinical AD, assessing AD-biomarkers is crucial. We investigated cognitive and neurodegenerative trajectories in SCD over 24...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Abstract INTRODUCTION Type 2 diabetes increases the risk of Alzheimer’s disease (AD) dementia. Insulin signaling dysfunction exacerbates tau protein phosphorylation, a hallmark of AD pathology. However, the comprehensive impact of diabetes on patterns of...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Anthony E. Lang, Günter U. Höglinger, Charles H. Adler, Daniela...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Clifford R. Jack Jr. | December 29, 2024 Wiley:...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Abstract INTRODUCTION Women with early bilateral salpingo-oophorectomy (BSO) have greater Alzheimer’s disease (AD) risk than women with spontaneous menopause (SM), but the pathway toward this risk is understudied. Considering associative memory deficits may...
